All changes for the tissue kidney (65)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA284
immunoglobulin lambda variable 4-3
Molecular
kidney
Human
IGLV4-3
41.0% Increase Gene Expression Level
DAA261
hypothetical LOC100126583
Molecular
kidney
Human
—
43.0% Increase Gene Expression Level
DAA260
hypothetical protein LOC284214
Molecular
kidney
Human
—
53.0% Increase Gene Expression Level
DAA259
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides
Molecular
kidney
Human
IGJ
60.0% Increase Gene Expression Level
DAA894
Interstitial fibrosis in medulla
Physiological
kidney
Human
—
—
DAA257
kininogen 1
Molecular
kidney
Human
KNG1
17.0% Decrease Gene Expression Level
DAA283
lactotransferrin
Molecular
kidney
Human
LTF
115.0% Increase Gene Expression Level
DAA270
lipoprotein lipase
Molecular
kidney
Human
LPL
17.0% Decrease Gene Expression Level
DAA905
Ability to secrete acid load decreases
Physiological
kidney
Human
—
—
DAA266
matrix metallopeptidase 7 (matrilysin, uterine)
Molecular
kidney
Human
MMP7
23.0% Increase Gene Expression Level
DAA2026
Mutations in mitochondrial DNA accumulate
Physiological
heart, kidney, skeletal muscle, cerebral cortex, cerebellum
Human
—
—
DAA279
nicotinamide N-methyltransferase
Molecular
kidney
Human
NNMT
40.0% Increase Gene Expression Level
DAA264
paraoxonase 3
Molecular
kidney
Human
PON3
13.0% Decrease Gene Expression Level
DAA278
Ras-related GTP binding D
Molecular
kidney
Human
RRAGD
14.0% Decrease Gene Expression Level
DAA2020
Reduction in renal function
Physiological
kidney
Human
—
—
DAA640
Renal failure
Pathological
kidney
Human
—
SeriesMorbidity
DAA276
Rh family, C glycoprotein
Molecular
kidney
Human
RHCG
16.0% Decrease Gene Expression Level
DAA282
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
Molecular
kidney
Human
SERPINA5
11.0% Decrease Gene Expression Level
DAA902
specific activities of enzymes are reduced
Molecular
kidney
Human
—
—
DAA268
solute carrier family 12 (sodium/chloride transporters), member 3
Molecular
kidney
Human
SLC12A3
16.0% Decrease Gene Expression Level
DAA286
StAR-related lipid transfer (START) domain containing 8
Molecular
kidney
Human
STARD8
14.0% Decrease Gene Expression Level
DAA901
telomere shortening
Molecular
kidney
Human
—
—
DAA277
tyrosinase-related protein 1
Molecular
kidney
Human
TYRP1
21.0% Decrease Gene Expression Level
DAA290
lysozyme (renal amyloidosis)
Molecular
kidney
Human
LYZ
57.0% Increase Gene Expression Level
DAA269
alpha-kinase 2
Molecular
kidney
Human
ALPK2
20.0% Increase Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA284 | immunoglobulin lambda variable 4-3 | Molecular | kidney | Human | IGLV4-3 | 41.0% Increase Gene Expression Level | |
DAA261 | hypothetical LOC100126583 | Molecular | kidney | Human | — | 43.0% Increase Gene Expression Level | |
DAA260 | hypothetical protein LOC284214 | Molecular | kidney | Human | — | 53.0% Increase Gene Expression Level | |
DAA259 | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | Molecular | kidney | Human | IGJ | 60.0% Increase Gene Expression Level | |
DAA894 | Interstitial fibrosis in medulla | Physiological | kidney | Human | — | — | |
DAA257 | kininogen 1 | Molecular | kidney | Human | KNG1 | 17.0% Decrease Gene Expression Level | |
DAA283 | lactotransferrin | Molecular | kidney | Human | LTF | 115.0% Increase Gene Expression Level | |
DAA270 | lipoprotein lipase | Molecular | kidney | Human | LPL | 17.0% Decrease Gene Expression Level | |
DAA905 | Ability to secrete acid load decreases | Physiological | kidney | Human | — | — | |
DAA266 | matrix metallopeptidase 7 (matrilysin, uterine) | Molecular | kidney | Human | MMP7 | 23.0% Increase Gene Expression Level | |
DAA2026 | Mutations in mitochondrial DNA accumulate | Physiological | heart, kidney, skeletal muscle, cerebral cortex, cerebellum | Human | — | — | |
DAA279 | nicotinamide N-methyltransferase | Molecular | kidney | Human | NNMT | 40.0% Increase Gene Expression Level | |
DAA264 | paraoxonase 3 | Molecular | kidney | Human | PON3 | 13.0% Decrease Gene Expression Level | |
DAA278 | Ras-related GTP binding D | Molecular | kidney | Human | RRAGD | 14.0% Decrease Gene Expression Level | |
DAA2020 | Reduction in renal function | Physiological | kidney | Human | — | — | |
DAA640 | Renal failure | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA276 | Rh family, C glycoprotein | Molecular | kidney | Human | RHCG | 16.0% Decrease Gene Expression Level | |
DAA282 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Molecular | kidney | Human | SERPINA5 | 11.0% Decrease Gene Expression Level | |
DAA902 | specific activities of enzymes are reduced | Molecular | kidney | Human | — | — | |
DAA268 | solute carrier family 12 (sodium/chloride transporters), member 3 | Molecular | kidney | Human | SLC12A3 | 16.0% Decrease Gene Expression Level | |
DAA286 | StAR-related lipid transfer (START) domain containing 8 | Molecular | kidney | Human | STARD8 | 14.0% Decrease Gene Expression Level | |
DAA901 | telomere shortening | Molecular | kidney | Human | — | — | |
DAA277 | tyrosinase-related protein 1 | Molecular | kidney | Human | TYRP1 | 21.0% Decrease Gene Expression Level | |
DAA290 | lysozyme (renal amyloidosis) | Molecular | kidney | Human | LYZ | 57.0% Increase Gene Expression Level | |
DAA269 | alpha-kinase 2 | Molecular | kidney | Human | ALPK2 | 20.0% Increase Gene Expression Level |